|
|
Volumn 6, Issue 4, 2011, Pages 299-313
|
|
AGO recommendations for diagnosis and treatment of patients with primary and metastatic breast cancer. update 2011
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
ANTIANEMIC AGENT;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CAPECITABINE;
CARBOPLATIN;
CISPLATIN;
COLONY STIMULATING FACTOR;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
EPIRUBICIN;
ESTROGEN RECEPTOR;
FLUOROURACIL;
FULVESTRANT;
GEMCITABINE;
INIPARIB;
KI 67 ANTIGEN;
LAPATINIB;
LETROZOLE;
METHOTREXATE;
NERATINIB;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
OLAPARIB;
PACLITAXEL;
PERTUZUMAB;
TAMOXIFEN;
TRASTUZUMAB;
UNINDEXED DRUG;
ADD ON THERAPY;
ADVERSE OUTCOME;
AMENORRHEA;
ANEMIA;
ARTICLE;
BODY MASS;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER DIAGNOSIS;
CANCER HORMONE THERAPY;
CANCER PATIENT;
CANCER PREVENTION;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER RISK;
CANCER SURGERY;
CANCER SURVIVAL;
CENTRAL NERVOUS SYSTEM METASTASIS;
CHEMOTHERAPY RELATED AMENORRHEA;
CLINICAL EFFECTIVENESS;
COGNITIVE DEFECT;
COMPARATIVE EFFECTIVENESS;
COMPRESSION GARMENT;
DEPRESSION;
DRUG DOSE ESCALATION;
ELECTROSTIMULATION;
FAMILIAL CANCER;
FATIGUE;
FEBRILE NEUTROPENIA;
FOLLOW UP;
GENETIC SUSCEPTIBILITY;
GESTATIONAL AGE;
HEART PROTECTION;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
INFECTION;
INSOMNIA;
INTRADUCTAL CARCINOMA;
INTRAOPERATIVE RADIOTHERAPY;
LYMPHADENECTOMY;
MAMMOGRAPHY;
MASTECTOMY;
MEDICAL SOCIETY;
MENOPAUSAL SYNDROME;
MENSTRUATION;
MULTIPLE CYCLE TREATMENT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OBESITY;
PATIENT COMPLIANCE;
PATIENT SAFETY;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRACTICE GUIDELINE;
PREGNANCY;
PREGNANCY OUTCOME;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RADIATION DOSE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REPRODUCTIVE TOXICITY;
RETROSPECTIVE STUDY;
SENTINEL LYMPH NODE BIOPSY;
SLEEP DISORDER;
TREATMENT CONTRAINDICATION;
TREATMENT DURATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TRIPLE NEGATIVE BREAST CANCER;
UNSPECIFIED SIDE EFFECT;
|
|
EID: 80052888728
PISSN: 16613791
EISSN: 16613805
Source Type: Journal
DOI: 10.1159/000331459 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
